Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

BACKGROUND: Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This study exami...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Ma, Ming-Chun, Chen, Yi-Ju, Chiu, Tai-Jan, Lan, Jui, Liu, Chien-Ting, Chen, Yi-Ching, Tien, Hsin-Ho, Chen, Yen-Yang
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5830052/
https://ncbi.nlm.nih.gov/pubmed/29486735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4146-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires